211 related articles for article (PubMed ID: 15322500)
1. Mutations in the gene encoding cytosolic beta-glucosidase in Gaucher disease.
Beutler E; Beutler L; West C
J Lab Clin Med; 2004 Aug; 144(2):65-8. PubMed ID: 15322500
[TBL] [Abstract][Full Text] [Related]
2. Mutation prevalence among 51 unrelated Spanish patients with Gaucher disease: identification of 11 novel mutations.
Alfonso P; Cenarro A; Pérez-Calvo JI; Giralt M; Giraldo P; Pocoví M
Blood Cells Mol Dis; 2001; 27(5):882-91. PubMed ID: 11783951
[TBL] [Abstract][Full Text] [Related]
3. The cytosolic β-glucosidase GBA3 does not influence type 1 Gaucher disease manifestation.
Dekker N; Voorn-Brouwer T; Verhoek M; Wennekes T; Narayan RS; Speijer D; Hollak CE; Overkleeft HS; Boot RG; Aerts JM
Blood Cells Mol Dis; 2011 Jan; 46(1):19-26. PubMed ID: 20728381
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: Pathogenic changes and "modifier" polymorphisms.
Montfort M; Chabás A; Vilageliu L; Grinberg D
Hum Mutat; 2004 Jun; 23(6):567-75. PubMed ID: 15146461
[TBL] [Abstract][Full Text] [Related]
5. Gaucher disease in Romanian patients: incidence of the most common mutations and phenotypic manifestations.
Drugan C; Procopciuc L; Jebeleanu G; Grigorescu-Sido P; Dussau J; Poenaru L; Caillaud C
Eur J Hum Genet; 2002 Sep; 10(9):511-5. PubMed ID: 12173027
[TBL] [Abstract][Full Text] [Related]
6. Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients.
Grabowski GA; Goldblatt J; Dinur T; Kruse J; Svennerholm L; Gatt S; Desnick RJ
Am J Med Genet; 1985 Jul; 21(3):529-49. PubMed ID: 3927728
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in glucosylceramide (glucocerebroside) synthase and the Gaucher disease phenotype.
Beutler E; West C
Isr Med Assoc J; 2002 Nov; 4(11):986-8. PubMed ID: 12489486
[TBL] [Abstract][Full Text] [Related]
8. Gaucher disease: expression and characterization of mild and severe acid beta-glucosidase mutations in Portuguese type 1 patients.
Amaral O; Marcão A; Sá Miranda M; Desnick RJ; Grace ME
Eur J Hum Genet; 2000 Feb; 8(2):95-102. PubMed ID: 10757640
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis and clinical findings in the Spanish Gaucher disease population: putative haplotype of the N370S ancestral chromosome.
Cormand B; Grinberg D; Gort L; Chabás A; Vilageliu L
Hum Mutat; 1998; 11(4):295-305. PubMed ID: 9554746
[TBL] [Abstract][Full Text] [Related]
10. Molecular screening of Japanese patients with Gaucher disease: phenotypic variability in the same genotypes.
Kawame H; Maekawa K; Eto Y
Hum Mutat; 1993; 2(5):362-7. PubMed ID: 8257989
[TBL] [Abstract][Full Text] [Related]
11. Type 1 Gaucher disease presenting with extensive mandibular lytic lesions: identification and expression of a novel acid beta-glucosidase mutation.
Wasserstein MP; Martignetti JA; Zeitlin R; Lumerman H; Solomon M; Grace ME; Desnick RJ
Am J Med Genet; 1999 Jun; 84(4):334-9. PubMed ID: 10340647
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a novel mutation c.1090G>T (G325W) and nine common mutant alleles leading to Gaucher disease in Spanish patients.
Torralba MA; Pérez-Calvo JI; Pastores GM; Cenarro A; Giraldo P; Pocoví M
Blood Cells Mol Dis; 2001; 27(2):489-95. PubMed ID: 11259172
[TBL] [Abstract][Full Text] [Related]
13. DNA mutational analysis of type 1 and type 3 Gaucher patients: how well do mutations predict phenotype?
Sidransky E; Bottler A; Stubblefield B; Ginns EI
Hum Mutat; 1994; 3(1):25-8. PubMed ID: 8118463
[TBL] [Abstract][Full Text] [Related]
14. Gaucher disease among Chinese patients: review on genotype/phenotype correlation from 29 patients and identification of novel and rare alleles.
Choy FY; Zhang W; Shi HP; Zay A; Campbell T; Tang N; Ferreira P
Blood Cells Mol Dis; 2007; 38(3):287-93. PubMed ID: 17196853
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients.
Suwannarat P; Keeratichamroen S; Wattanasirichaigoon D; Ngiwsara L; Cairns JR; Svasti J; Visudtibhan A; Pangkanon S
Blood Cells Mol Dis; 2007; 39(3):348-52. PubMed ID: 17689991
[TBL] [Abstract][Full Text] [Related]
16. Genetic heterogeneity in type I Gaucher disease.
Devine EA; Beighton P; Petersen EM; Desnick RJ
Prog Clin Biol Res; 1982; 95():495-510. PubMed ID: 6812084
[TBL] [Abstract][Full Text] [Related]
17. Biochemical properties of beta-glucosidase in leukocytes from patients and obligated heterozygotes for Gaucher disease carriers.
Michelin K; Wajner A; Bock H; Fachel A; Rosenberg R; Pires RF; Pereira ML; Giugliani R; Coelho JC
Clin Chim Acta; 2005 Dec; 362(1-2):101-9. PubMed ID: 16039637
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of Turkish Gaucher disease patients: identification of novel mutations in glucocerebrosidase (GBA) gene.
Emre S; Gürakan F; Yüce A; Rolf A; Scott R; Ozen H
Eur J Med Genet; 2008; 51(4):315-21. PubMed ID: 18586596
[TBL] [Abstract][Full Text] [Related]
19. New insights into the origin of the Gaucher disease-causing mutation N370S: extended haplotype analysis using the 5GC3.2, 5470 G/A, and ITG6.2 polymorphisms.
Rodríguez-Marí A; Díaz-Font A; Chabás A; Pastores GM; Grinberg D; Vilageliu L
Blood Cells Mol Dis; 2001; 27(5):950-9. PubMed ID: 11783960
[TBL] [Abstract][Full Text] [Related]
20. Acid beta-glucosidase: enzymology and molecular biology of Gaucher disease.
Grabowski GA; Gatt S; Horowitz M
Crit Rev Biochem Mol Biol; 1990; 25(6):385-414. PubMed ID: 2127241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
